Quick Takeaways
- Steven H. Stein has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $6,894,478.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Steven H. Stein and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| INCY | INCYTE CORP | CMO & Head of Late-Stage Dev. | $6,894,478 | -$5,724,778 | -45% | 15 Apr 2026 |
| THRX | Theseus Pharmaceuticals, Inc. | Director | $0 | 14 Feb 2024 | ||
| KURA | Kura Oncology, Inc. | Director | 21 Jun 2022 | |||
| RPTX | Repare Therapeutics Inc. | Director | 17 Jun 2024 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|